Literature DB >> 35698012

Decoding Fine API Agglomeration as a Key Indicator of Powder Flowability and Dissolution: Impact of Particle Engineering.

Sangah Kim1, Mirna Cheikhali1, Rajesh N Davé2.   

Abstract

PURPOSE: Fine API agglomeration and its mitigation via particle engineering, i.e., dry coating, remains underexplored. The purpose was to investigate agglomeration before and after dry coating of fine cohesive APIs and impact on powder processability, i.e., flowability (FFC), bulk density (BD), and dissolution of BCS Class II drugs.
METHOD: Ibuprofen (three sizes), fenofibrate, and griseofulvin (5-20 µm), before and after dry coating with varying amounts of hydrophobic (R972P) or hydrophilic (A200) nano- silica, were assessed for agglomeration, FFC, BD, surface energy, wettability, and dissolution. The granular Bond number (Bog), a dimensionless parameter, evaluated through material-sparing particle-scale measures and particle-contact models, was used to express relative powder cohesion.
RESULTS: Significant powder processability improvements after dry coating were observed: FFC increased by multiple flow regimes, BD increased by 25-100%, agglomerate ratio (AR) reduction by over an order of magnitude, and greatly enhanced API dissolution rate even with hydrophobic (R972P) silica coating. Scrutiny of particle-contact models revealed non-triviality in estimating API surface roughness, which was managed through the assessment of measured bulk properties. A power-law correlation was identified between AR and Bog and subsequently, between AR and FFC & bulk density; AR below 5 ensured improved processability and dissolution.
CONCLUSION: Agglomeration, an overlooked material-sparing measure for powder cohesiveness, was a key indicator of powder processability and dissolution. The significant agglomerate reduction was possible via dry coating with either silica type at adequate surface area coverage. Reduced agglomeration after dry coating also countered the adverse impact of increased surface hydrophobicity on dissolution.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  dry coating; granular bond number; powder agglomeration; powder processability; powder roughness

Year:  2022        PMID: 35698012     DOI: 10.1007/s11095-022-03293-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology.

Authors:  Jiahui Hu; True L Rogers; Judith Brown; Tim Young; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

2.  Improvement of flow and bulk density of pharmaceutical powders using surface modification.

Authors:  Laila J Jallo; Chinmay Ghoroi; Lakxmi Gurumurthy; Utsav Patel; Rajesh N Davé
Journal:  Int J Pharm       Date:  2011-12-17       Impact factor: 5.875

3.  Passivation of high-surface-energy sites of milled ibuprofen crystals via dry coating for reduced cohesion and improved flowability.

Authors:  Xi Han; Laila Jallo; Daniel To; Chinmay Ghoroi; Rajesh Davé
Journal:  J Pharm Sci       Date:  2013-05-08       Impact factor: 3.534

4.  Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.

Authors:  Xi Han; Chinmay Ghoroi; Daniel To; Yuhua Chen; Rajesh Davé
Journal:  Int J Pharm       Date:  2011-06-12       Impact factor: 5.875

5.  Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.

Authors:  Xi Han; Chinmay Ghoroi; Rajesh Davé
Journal:  Int J Pharm       Date:  2012-08-08       Impact factor: 5.875

6.  Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.

Authors:  Anagha Bhakay; Mohammad Azad; Ecevit Bilgili; Rajesh Dave
Journal:  Int J Pharm       Date:  2013-12-11       Impact factor: 5.875

Review 7.  The toxicity of silica nanoparticles to the immune system.

Authors:  Liangjiao Chen; Jia Liu; Yanli Zhang; Guilan Zhang; Yiyuan Kang; Aijie Chen; Xiaoli Feng; Longquan Shao
Journal:  Nanomedicine (Lond)       Date:  2018-08-28       Impact factor: 5.307

8.  Polymer strip films as a robust, surfactant-free platform for delivery of BCS Class II drug nanoparticles.

Authors:  Scott M Krull; Ramana Susarla; Afolawemi Afolabi; Meng Li; Ye Ying; Zafar Iqbal; Ecevit Bilgili; Rajesh N Davé
Journal:  Int J Pharm       Date:  2015-04-15       Impact factor: 5.875

9.  Improving blend content uniformity via dry particle coating of micronized drug powders.

Authors:  Zhonghui Huang; Wannan Xiong; Kuriakose Kunnath; Sayani Bhaumik; Rajesh N Davé
Journal:  Eur J Pharm Sci       Date:  2017-04-20       Impact factor: 4.384

Review 10.  Insoluble drug delivery strategies: review of recent advances and business prospects.

Authors:  Sandeep Kalepu; Vijaykumar Nekkanti
Journal:  Acta Pharm Sin B       Date:  2015-08-24       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.